HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1473293Generated: October 30, 2026
Hydrochloric Acid → 5-(4-Chloro-2-(1H-pyrazol-4-YL)phenyl)-N-(1,2,4-thiadiazol-5-YL)naphthalene-2 sulfonamide
https://huagongshe.com/reaction/1473293
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | tert-butyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate | HCID 16217654 | — |
| Reactant | 5-(2-Bromo-4-chlorophenyl)-N-(2,4-dimethoxybenzyl)-N-(1,2,4-thiadiazol-5-YL)naphthalene-2-sulfonamide | HCID 86687347 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | 5-(4-Chloro-2-(1H-pyrazol-4-YL)phenyl)-N-(1,2,4-thiadiazol-5-YL)naphthalene-2 sulfonamide | HCID 89614508 | — |
Reaction Steps
A pressure vessel was charged with 5-(2-bromo-4-chlorophenyl)-N-(2,4-dimethoxybenzyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (0.8 g, 1.268 mmol), potassium carbonate (1.227 g, 8.88 mmol), tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate (0.748 g, 2.54 mmol), tetrakis(triphenylphosphine)palladium(0) (0.147 g, 0.127 mmol), dioxane (8.45 mL) and water (4.23 mL). The reaction was heated in a microwave at 100° C. for 30 min. The reaction mixture was cooled to room temperature and 2N HCl (10 mL) was then added dropwise to neutralize the base. The aqueous layer was then washed with DCM (three times). The organic layers were combined and dried over sodium sulfate, filtered over a layer of diatomaceous Earth® (diatomaceous earth) and concentrated under a vacuum to provide a yellow oil. To this oil was added DCM (12.68 mL, 1.268 mmol) and TFA (0.488 mL, 6.34 mmol). The resulting mixture was stirred for 1 h at rt. LC/MS indicated that the dimethoxybenzyl (DMB)-protected intermediate remained. The mixture was then heated to 50° C. for 1 h. LC/MS indicated that the desired product (M+H=467.8) was generated. The mixture was concentrated, diluted with DCM (3 mL) and purified by reverse phase HPLC using a Phenomenex Gemini 5 μm, C18, 110 Å, 150×30 mm column eluting with a mixture of 0.1% TFA in acetonitrile/water. The fractions containing product were dried to provide a white solid. 5-(4-chloro-2-(1H-pyrazol-4-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (0.165 g, 0.352 mmol). 1H NMR (500 MHz, DMSO-d6) δ ppm 2.08 (s, 2H) 2.54 (s, 1H) 7.02 (br. s., 2H) 7.30 (d, J=8.23 Hz, 1H) 7.40-7.47 (m, 2H) 7.56 (d, J=7.05 Hz, 1H) 7.65 (dd, J=8.87, 1.92 Hz, 1H) 7.69-7.76 (m, 1H) 7.79 (d, J=2.14 Hz, 1H) 8.26 (d, J=8.23 Hz, 1H) 8.44 (s, 1H) 8.53 (d, J=1.71 Hz, 1H); m/z (ESI) 467.8 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09012443B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-5e46f7f8d01645d3a14cd4cf36c7716c |
|---|
| Source note | uspto-grants-2015_04 |
|---|